Valuing prevention through economic evaluation Jasper M. BosPhilippe BeutelsMaarten J. Postma Current Opinion 17 September 2012 Pages: 1171 - 1179
Economic costs to business of the HIV/AIDS epidemic Gordon G. LiuJeff J. GuoScott R. Smith Review Article 17 September 2012 Pages: 1181 - 1194
Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma Adele WestonPatrick FitzGerald Original Research Article 17 September 2012 Pages: 1195 - 1208
The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratios Elinor C. G. ChumneyAndrea K. BiddleWilliam N. Zelman Original Research Article 17 September 2012 Pages: 1209 - 1216
The economic implications of non-adherence after renal transplantation Irina CleemputKatrien KestelootSabina De Geest Original Research Article 17 September 2012 Pages: 1217 - 1234